chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Systemic: warm and sweaty face--hot face-Mild, Systemic: Flushed / Sweating-Mild, Additional Details: pt waited a half hour--vitals were monitored by nursepractioner---122/78 hr in 80s---pt was walked out to car with husband waiting  by employee---total dose benadryl 50mg--chewable and then liquid--pt immediately felt better after laying down--Np feels it was vasovagal
Information has been received from a nurse, concerning a 20 year old female student, who on 06-MAR-2007 at 11:00 am, was vaccinated with the first dose, 0.5ml, IM in the left deltoid, of Gardasil (Lot # 654702/0011U). The nurse reported that "approximately 5 minutes after" the vaccination (time reported as 11:15am), the patient "felt lightheaded and fainted, lost consciousness for approximately less than a minute." The nurse stated that the patient complained of feeling "strange in her head" and experienced abdominal cramps" that lasted for approximately 20 minutes. The nurse indicated that the patient had not had breakfast that morning and felt better after drinking some orange juice. The patient recovered from the events on 07-MAR-2007. No further information is expected.
14OCT98 c/o cough, sinus & chest congestive w/clear sinus drainage 4hr p/vax;states sclera reddened eyes burning w/h/a & weakness lasting 8hr;states took DPH/aleve x2 3hr apart;sx resolved;
Onset of Headache, Sinuses swelling, pain in eyes, nose, teeth, neck and chills about 3:15;  Temp 100.1 at 5:30 with severe body aches;  Temp of 101 with all previous symptoms and difficulty breathing through nose at 6:00.  Treated with: Excederin + oxycodone (per Emory Dr on call)- temp down to normal at 11:55.  Today (October 17th), body aches and extreme fatigue.
there is pain radiating down the right side of her back and in the right side of her head and temple; Bad pain on right side of head, neck, and back; mild - moderate headache; This is a spontaneous report from a contactable consumer.  A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 30Dec2020 11:15 on the left arm at single dose for COVID-19 immunisation.  Medical history included immune disorder with high inflammatory markers, gluten intolerance, she is ANA positive (last time she was tested it was 2800) and allergic to sulfites.  The patient's concomitant medications were not reported.  The patient stated "she received vaccine on 30Dec2020. For the first 24 hours had no side effects, then developed a mild headache after 24 hours and 24 hours after that it worsened and developed pain on the right side of her neck that is like the stem of her headache and there is pain radiating down the right side of her back and in the right side of her head and temple. States that since this developed, it has persisted, not gotten worse or better. Wants to clarify that this does not involve her arms just her neck, head and back. States no amount of pain medication is working to relieve the pain. Ibuprofen is normally her go to and it did not work, she then tried the ADVIL LIQUIGELS, she took 400mg, states it was not working, she then got Bayer Back and Body to try because it has Aspirin in it, took 1500mg, three total pills, helped for an hour and then pain came back. Also tried a daytime THERAFLU just trying to get rid of the body aches, Good Sense Daytime Cold and Flu". The outcome of the events was not recovered.   Information on the lot/batch number has been requested.
After vaccine administered, patient bled stream down arm but stopped after cotton swab applied. Mild bruising and swelling around vaccine site. Pt calm.
1/25/05 recieved Hep B Booster right arm. Slight rash (prickly) about torso (leftside) appeared and slight inner pain noticed right side under rib gage area approx 3 days after injection. Returned to home state & seen by private Doctor approx 8 days after injection Re: abdominal pain & rash. Ultrasound conducted for possible gallbladder, etc with negative findings.  Complete blood & urine conducted. Everything normal except slightly elevated potassium & white blood cell level. Dr. not concerned. Advised to apply Elidel or hydrocortisone to rash. DR could not explain rash giving several possible reasons.  Departed for 1 week stay before deploying overseas on 2/12/05.  Rash unchanged between these dates.  On or about 2/14/05 rash about torso (both sides), neck, upper arms & legs became extremely inflamed (redness, itchy, prickly). Applied creams with negative relief.  On 2/16/05 was seen by Dr. Re: same plus upper respiratory infection.  Dr. Unable to determine cause of rash giving several possible reasons.  Patient indicated concerns about Bohn's Syndrome (Hep B vaccine reaction). Dr advised patient to make report with VAERS.  Prescribed Triamcinol acetonice cream for rash & med for congestion.  Stated to wait a week for results.
pt recv vax -next day had gen diffused maculopapular lesions to trunk, lower abd, no resp problems, no hives, no angioedema;pt did recv 1st IPV, DTAP the wk before;pt recovered w/in 24hr uneventfully;
DIZZINESS; BLURRY VISION; SLIGHTLY SWOLLEN  RIGHT EYE; BLACK RIGHT EYE; FLU LIKE SYMPTOMS OF GENERAL ACHES AND CHILLS; THROBBING PAIN ON RIGHT ARM AT INJECTION SITE; HEADACHE; This spontaneous report received from a patient concerned a 53 year old female. The patient's height, and weight were not reported. The patient's past medical history included iga nephropathy, hypothyroid disease, and anemia, and concurrent conditions included alcohol user, and non smoker, and other pre-existing medical conditions included the patient did not have any drug abuse or illicit drug usage. The patient was previously treated with levothyroxine sodium for hypothyroid disease, iron for anemia, and midazolam hydrochloride for iga nephropathy; and experienced severe full body rash when treated with capsaicin/menthol, and drug allergy when treated with naproxen sodium. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 203A21A, expiry: 23-JUN-2021) dose was not reported, administered on 12-APR-2021 11:00 for prevention of covid 19. No concomitant medications were reported. On 12-APR-2021, the subject experienced throbbing pain on right arm at injection site. On 12-APR-2021, the subject experienced headache. On 13-APR-2021 21:00, the subject experienced flu like symptoms of general aches and chills. On 14-APR-2021, the subject experienced slightly swollen right eye. On 14-APR-2021, the subject experienced black right eye. On 14-APR-2021, the subject experienced dizziness. On 14-APR-2021, the subject experienced blurry vision. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu like symptoms of general aches and chills on 14-APR-2021, and had not recovered from slightly swollen right eye, throbbing pain on right arm at injection site, headache, dizziness, blurry vision, and black right eye. This report was non-serious.
Approx 2.5-2 hrs p/immun pt became extremely lighthead, dizzy when standing he was not hypotensive but was orthostatic by pulse & pressure changes;
Patient recieved 21/22 Fluzon eHD exp 6/30/2022- no reaction reported
Had injection site pain; Also had redness of the injected arm; This case was reported by a physician via sales rep and described the occurrence of injection site pain in a 14-year-old male patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero (intramuscular) and Bexsero Pre-Filled Syringe Device. On an unknown date, less than a day after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced injection site pain and erythema of extremities. On an unknown date, the outcome of the injection site pain and erythema of extremities were recovered/resolved.   The reporter considered the injection site pain and erythema of extremities to be related to Bexsero and Bexsero Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follow: The case was reported by a pediatrician via sales representative. The patient received 1st dose of Bexsero in an unspecified deltoid. The patient immediately after got home called the physician office and said that he had injection site pain. The patient also had redness of the injected arm which went from the shoulder all the way down to the hand and lasted 3 days. The physician stated that all events had resolved.  The physician stated that Bexsero was the only vaccination that patient received that day. No further information was provided.
Pt. reported swollen arm, red, itchy, pain at injection site, shortness of breath, blurred vision and not feeling well w/ fever 9 pays past vaccination. Had to visit the ER
Patient experienmced some tingling in his finger on his left hand started about 3 minutes after receiving the vaccine. mom allowed pt to take a 25 mg benadryl.  pt the brought up to clinic. The nurse practioner up there said pt did fine and she sent him home with mom after monitoring for about 20 minutes.
2 hours after vaccination started to feel dizzy and see "stars". As the day went on I developed a headache and I felt as if I was "drugged".  I felt weak and sick.  I became very warm. My heart "hurt" and had a rapid heartbeat. My thought processes were affected, my reactions slow.  I felt sick all day Wednesday, Thursday and most of Friday.  I called my doctor.  RN stated that if I continued to feel sick, I should report to the Emergency Department.  I am worried about residual effects froms the vaccination.
Client felt tired on Friday after vaccine, on Saturday (2/6) clients arm was red and swollen, and she had some shortness of breath.  Daughter said these symptoms progressively got worse.  On 2/8 client went to MD who told her it was an allergic reaction and that she should report it to her local Health department.
Bell's Palsy  Left eyelid has been drooping closed x 2 wk.  Pain in eye is inside eye, feels like something pulling from inside. Face on left also swollen.
My throat was getting scratchy, and I was coughing. I took a home COVID test and it was positive. I took a shower and then went to bed. I had no strength at all. I had a fever and then I took TYLENOL. I was trying to get over the coughing and shortness of breath.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose:01/06/21pfizer,Lot#EL3246 2nd dose: 01/27/21 Pfizer,Lot# EL9262 Diagnosed covid positive:04/07/21 Exposure:Home Exposure Symptoms:Fatigue,Sorethroat,nausea,vomiting,Rhinorrhea,HA
low energy; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 immunisation. The following information was reported: ASTHENIA (non-serious), outcome "unknown", described as "low energy". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
While I did experience chills, pain at site, malaise, and general aches the evening of the injection, several days later I also noticed a constant headache with continued malaise.  When I felt my head/skull where it hurt the most, I noticed lumps/bumps which ran upward from my upper neck along the route of my occipital nerve on the right side of my skull.   I also noted an enlarged lymph node behind my right ear. These were tender to touch and made it hard to sleep laying on my right side.  I did not have fever, chills, sore throat or other issues.  But after two weeks of  the tender bumps and headache, I became suspicious that I was actually experiencing a case of Shingles.  When I awoke on 3/24/20 with a new small vesicle on my eyelid, I became more concerned.  So I made an appt. to see my MD where she did confirm that she felt I had a case of shingles and started me on a course of cortisone and Valacyclovir.
Splotchy, red, hives-like rash prominent on feet, hands, knees, rear thigh/hip area. Itchy and painful. Resolved with Benadryl within 12 hours.
This spontaneous report was received from a pharmacist refers to patient of unknown age and gender. The patient's concurrent conditions, medical history and drug reactions and allergies was unknown. The patient's concomitant therapy included sterile diluent. On 21-Oct-2017, the patient was vaccinated with one dose of improperly stored ZOSTAVAX (units and frequency were unknown) (Lot # M040146 and expiration date 26-DEC-2017) for prophylaxis. Reporter informed that, there was temperature excursions for the ZOSTAVAX (Lot # M040146 and expiration date 26-DEC-2017) at a temperature of 15°F to 46°F and time frame 14 hours 30 minutes. There was no previous temperature excursion. The call was because of a data logger. No adverse effects were reported. There was no product quality compliant reported.
Itchy rash on stomach erupted 7 days from shot and was active (growing) for 2-3 days. Began healing after about 5 days,  Some single spots on extremities.
Caller was diagnosed with a UTI; This is a spontaneous report from a contactable consumer (patient). A 74-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and expiration date was not reported), via an unspecified route of administration on 19Mar2021 as dose 2, single for COVID-19 immunization (at the age of 74-year-old); tofacitinib citrate (XELJANZ XR), via an unspecified route of administration from Feb2021 (Batch/Lot number was not reported) to an unspecified date, at unspecified dose for an unspecified indication. Historical vaccine included first dose of BNT162B2 (Lot number: not reported) via an unspecified route of administration on 24Feb2021 for COVID-19 immunization (at the age of 74-year-old). The patient's medical history and concomitant medications were not reported. The patient experienced caller was diagnosed with a UTI (urinary tract infection) on an unspecified date in Jun2021. It was reported that, patient was diagnosed with a UTI a couple months ago around Jun2021 and was prescribed an antibiotic for it. Patient was taking XELJANZ XR 11 mg that he started taking in early Feb2021 before getting both doses of the Pfizer Covid-19 vaccine and was asking if he should stop it if he gets the booster dose of the Pfizer Covid-19 vaccine. Caller was asking if the booster of the Pfizer Covid-19 vaccine would be more effective if he holds the Xeljanz. Patient stated that, his HCP had recommended that he gets the booster dose of the Pfizer Covid-19 vaccine. Patient did not know if he needs to stop the medication Xeljanz XR 11 mg that he took while he got the booster. Patient was treated with antibiotic as a result UTI. The outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
"nodded off"; "kind of tired" AND felt a stronger tiredness"; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE ("nodded off") and FATIGUE ("kind of tired" AND felt a stronger tiredness") in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included Heart attack in May 2017. Concurrent medical conditions included Penicillin allergy and Uterine cancer. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), ATORVASTATIN and GABAPENTIN for an unknown indication.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced SOMNOLENCE ("nodded off") and FATIGUE ("kind of tired" AND felt a stronger tiredness"). At the time of the report, SOMNOLENCE ("nodded off") and FATIGUE ("kind of tired" AND felt a stronger tiredness") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Flu like symptoms, and preterm labor resulting in the loss of twins at 20 weeks.
Received Menactra approximately 10 AM on 1/28/14. Noted hives on legs later that evening. Gave Benadryl - hives improved. Hives became progressively worse over next 24-48 hrs.
Developed fever approx. 23 hours after receiving vaccine.  Temperature 102.1; sent home from work.
I developed a painful, red, swollen bump on my top knuckle, The swelling went down after the first day, but I continue to have a red bruise-like thing on that spot. It's painful to the touch, much like a bruise, but has not improved or started to heal in any way that I can tell.
Mother of patient called with following: child had H1N1 (1) 12-1-09. H1N1 (2) 12-16-09. 1-1-10 Child had strept throat dg. by MD. 1-8-10 Child had stomach virus, da. by MD. 2-8-10 Child had nausea-vomiting. Mother related it to H1N1 vaccine.  Follow-up received states - Parent did not provide child's DOB or phone number. Immunization occurred at a public adm. site. I have no knowledge of place or vaccine lot number.
Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021; Patient received Moderna vaccine past its 30 days expiry date; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received Moderna vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2022 at 3:25 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 28-Jan-2022 at 3:25 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received Moderna vaccine past its 30 days expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received Moderna vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by reporter.  Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021, this vaccine was administered up until its manufacturing expiry date of 04-Apr-2022.   No treatment medication was reported by reporter.
Patient called clinic 4/14/2021 stating the day after she received the vaccine she had chills, fatigue, extreme pain, pain in the lower back all the way to feet, and discomfort in hands and feet.
This spontaneous report as received from a medical assistant refers to multiple unspecified patients of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medication were not reported. On an unknown date, the patients were vaccinated orally with improperly stored doses of ROTATEQ lot # K015843, expiration date 04-MAY-2016, lot # K022995, expiration date 22-JUL-2016 (doses were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Initial solicited report received on 17 August 2016 from an investigator participating in the below mentioned study. This case involves a six-year-old subject who had a bad reaction to flu shot at 16 months that almost killed him during the study participation. The subject's medical history was not reported. The subject's concomitant therapies were not reported. The subject received the INFLUENZA QUADRIVAL A-B VACCINE on an unknown date. In consumer online market research survey about flu vaccination. The subject had bad reaction to flu shot at 16 months that almost killed him. The subject had no agreed to be identified or provide further information. No relevant physician or other reporter can be identified to provide additional information. According to investigator the event was considered as life threatening. The lab data and corrective treatment were not reported. The event of 6 year old had a bad reaction to flu shot at 16 months that almost killed him was ongoing at the time of report. Causal relationship as per reporter was not reported. Relationship to investigational product according to company: not associated. The serious adverse event did not lead to the termination of the subject from the study. List of documents held by sender: none. Sender's Comments: A six-year-old female subject had bad reaction (not specified) to flu shot at 16 months that almost killed him. Details regarding nature of reaction, latency from vaccination, medical history of the patient, vaccination history, concomitant medications, immune status of the patient and reporter causality were not reported. Based on limited data available, the sponsor assesses this event as not related to study vaccine or trial procedure.
This spontaneous report as received from a medical assistant refers to a 3 year old patient. No concurrent conditions, medical history, allergy/drug reactions and concomitant medications were reported. The patient's past vaccination included a VARIVAX (Merck) lot# L037561, expiry date: 29-SEP-2017 on an unknown date. On 14-MAR-2016, the patient was vaccinated with PROQUAD (Merck) (dosing details and route not reported) lot # L046509, expiry date: 17-MAY-2017, instead of M-M-R II. No adverse effects were reported. There were no product quality complaints (PQC) involved. Additional information has been requested.
This spontaneous report as received from an other health professional refers to a patient of unknown age. On 29-AUG-2017, the patient was vaccinated with improperly stored dose of RECOMBIVAX HB lot # L020157 for prophylaxis. No adverse effects were reported.
15APR91 extreme swelling & redness @ inject site; Felt faint, h/a, dizzy;
Turf toe surgery 9/3/2021. Chest pain for 24 hours starting 9/4/2021. He stopped opioids that were temporarily prescribed for turf toe. THis revealed a 103F. He went to ER where he  had elevated troponins. He received IV fluids and possibly IV antibiotics. He was monitored for 20 hours and then was sent home without medication per his memory. He was told he had myocarditis.
Moderna COVID-19 Vaccine EUA  Both hands with red rash after over 5 hours after vaccination, no other rashes or pain.
Fever, headache, difficulty swallowing. Benadryl, Tylenol and pushed fluids...slowly recovering!!
Patient was administered the Td vaccine on 2/1/21, which had an expiration date of 1/28/21. PATIENT denied having any side effects from the vaccine.